Previous close | 1.2000 |
Open | 1.2000 |
Bid | 1.0000 |
Ask | 1.3000 |
Strike | 1.00 |
Expiry date | 2026-01-16 |
Day's range | 1.2000 - 1.2100 |
Contract range | N/A |
Volume | |
Open interest | 482 |
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), today announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation. This innovative resource fills a critical void for rare disease researchers, providing access to genetic variants that are not detectable through short-read sequencing methods. B
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Why does Cathie Wood think investors' fear about stocks is at "Great Depression" levels? Because it is for her portfolio.